central nervous system uptake of intranasal glutathione in parkinson's disease Sunday Morning with Laurie Mischley
Sunday Morning with Laurie Mischley June 14, 2020 YouTube Organelle targeted nanotherapeutics for parkinson's disease: From pa IJN Dove Medical Press Innovative approach in Parkinson's targeting via berberine loaded mucoadhesive surface modified liposomes: a multi faceted study BMC Pharmacology and Toxicology Springer Nature Link The Central Nervous System Modulatory Activities of N Acetylcysteine: A Synthesis of Two Decades of Evidence Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease ScienceDirect Unlocking the potential of lipid based nanoparticles for intranasal drug delivery in Parkinson's disease ScienceDirect
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21





